Literature DB >> 18585852

Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease.

Roberto Zulli1, Franco Nicosia, Barbara Borroni, Chiara Agosti, Paola Prometti, Paolo Donati, Massimiliano De Vecchi, Daniele Turini, Giuseppe Romanelli, Vittorio Grassi, Alessandro Padovani.   

Abstract

OBJECTIVE: To assess the prevalence and the characteristics of silent myocardial ischaemia (SMI) and ventricular arrhythmias (VA) in subjects with Alzheimer's disease (AD) and mild cognitive impairment (MCI) and their relationships with QT interval dispersion (QTD).
METHODS: Thirty-three subjects with AD, 39 subjects with MCI, and 29 cognitive healthy control subjects matched for demographic characteristics, hypertensive condition, smoking habits, and laboratory parameters were enrolled. Each subject underwent clinical and cognitive examination, a structural brain imaging study, electrocardiogram (ECG), 24-h ECG recording, 24-h blood pressure monitoring, and echocardiogram. Detection and characterization of QT dispersion, SMI and VA were performed.
RESULTS: The three groups were comparable regarding demographic and basal cardiovascular characteristics: notwithstanding this, SMI episodes were observed only in AD and MCI patients (19 and 14, respectively). A significantly greater prevalence of repetitive ventricular premature beats was observed in AD (mean 8.56+/-13.1) and in MCI (1.8+/-7.2) vs. control (0.7+/-1.7). The QTD, the ischaemic burden and the number of repetitive ventricular beats revealed to be significantly related.
CONCLUSIONS: Increased prevalence of SMI and potentially ominous VA were found in AD and, to a lesser extent, in MCI. SMI and repetitive VA were significantly related with QTD. These findings could be related to an increased risk of sudden cardiac death in AD and MCI patients.

Entities:  

Mesh:

Year:  2008        PMID: 18585852     DOI: 10.1016/j.clineuro.2008.05.002

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  8 in total

1.  Coronary artery disease affects cortical circuitry associated with brain-heart integration during volitional exercise.

Authors:  Katelyn N Norton; Mark B Badrov; Carly C Barron; Neville Suskin; Armin Heinecke; J Kevin Shoemaker
Journal:  J Neurophysiol       Date:  2015-05-13       Impact factor: 2.714

Review 2.  Associations between Sleep, Cortisol Regulation, and Diet: Possible Implications for the Risk of Alzheimer Disease.

Authors:  Francesca Pistollato; Sandra Sumalla Cano; Iñaki Elio; Manuel Masias Vergara; Francesca Giampieri; Maurizio Battino
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

3.  The relationship between regional brain volumes and the extent of coronary artery disease in mild cognitive impairment.

Authors:  Majid Barekatain; Hedyeh Askarpour; Faezeh Zahedian; Mark Walterfang; Dennis Velakoulis; Mohammad Reza Maracy; Mohammad Hashemi Jazi
Journal:  J Res Med Sci       Date:  2014-08       Impact factor: 1.852

4.  Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment.

Authors:  Majid Barekatain; Faezeh Zahedian; Hedyeh Askarpour; Mohammad Reza Maracy; Mohammad Hashemi-Jazi; Mohammad Reza Aghaye-Ghazvini
Journal:  ARYA Atheroscler       Date:  2014-09

5.  Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Irina Chadaeva; Dmitry A Rasskazov; Ekaterina Sharypova; Elena V Kashina; Irina Drachkova; Dmitry Zhechev; Mikhail P Ponomarenko; Ludmila K Savinkova; Nikolay Kolchanov
Journal:  Front Aging Neurosci       Date:  2017-07-20       Impact factor: 5.750

6.  Association of nurse staffing grade and 30-day mortality in intensive care units among cardiovascular disease patients.

Authors:  Jae-Hyun Kim
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  The Protective Effects of Clams on Hypercholesterolemia in Late-Stage Triple-Transgenic Alzheimer's Diseased Mice Hearts.

Authors:  You-Liang Hsieh; Hsu-Ju Teng; Yen-Hung Yeh; Cheng-Hong Hsieh; Chih-Yang Huang
Journal:  Mar Drugs       Date:  2018-08-01       Impact factor: 5.118

8.  Incident prolonged QT interval in midlife and late-life cognitive performance.

Authors:  Claudia K Suemoto; Laura E Gibbons; Evan L Thacker; Jonathan D Jackson; Claudia L Satizabal; Brianne M Bettcher; Lenore Launer; Caroline Phillips; Lon R White; Melinda C Power
Journal:  PLoS One       Date:  2020-02-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.